Personalis, Inc. (PSNL): Price and Financial Metrics
PSNL Price/Volume Stats
| Current price | $5.06 | 52-week high | $7.20 |
| Prev. close | $5.15 | 52-week low | $1.13 |
| Day low | $4.95 | Volume | 972,500 |
| Day high | $5.39 | Avg. volume | 928,390 |
| 50-day MA | $4.09 | Dividend yield | N/A |
| 200-day MA | $4.69 | Market Cap | 446.92M |
PSNL Stock Price Chart Interactive Chart >
Personalis, Inc. (PSNL) Company Bio
Personalis, Inc. provides genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.
PSNL Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PSNL Price Returns
| 1-mo | 4.55% |
| 3-mo | 22.22% |
| 6-mo | 21.93% |
| 1-year | 261.43% |
| 3-year | 31.77% |
| 5-year | -62.10% |
| YTD | -12.46% |
| 2024 | 175.24% |
| 2023 | 6.06% |
| 2022 | -86.12% |
| 2021 | -61.02% |
| 2020 | 235.87% |